Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder

16 references·2 citing·43 second hop

FromToDepth

this work references cited by second hop

References

1983The Hospital Anxiety and Depression Scale47,092 cited
1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
1959THE ASSESSMENT OF ANXIETY STATES BY RATING11,442 cited
2011The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults5,145 cited
2012Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States2,944 cited
2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision860 cited
2008Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale469 cited
2006Human and economic burden of generalized anxiety disorder437 cited
2007Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial286 cited
2007An effect-size analysis of pharmacologic treatments for generalized anxiety disorder179 cited
2011Evidence-based pharmacological treatment of generalized anxiety disorder168 cited
2006Clinical practice guidelines. Management of anxiety disorders.161 cited
2007Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder91 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2002

Generalized anxiety disorder in primary care: emerging issues in management and treatment.

79 cited

2010Site Versus Centralized Raters in a Clinical Depression Trial68 cited

2012Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States55 cited

Cited by

2020Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials44 cited
2019Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis39 cited